The UK’s Medicines and Healthcare products Regulatory Agency (MHRA) has launched a consultation on regulatory guidance for ...

Biotech investing can be tricky. Often, the drugs that these fledgling companies produce don’t pan out, and shareholders take ...

Hyderabad: Vaccine maker Bharat Biotech invested Rs 1,500 crore in setting up what is touted as one of the world's largest vaccine manufacturing facil.

Key Takeaways Moderna received a $590 million award from the U.S. government to speed development of a vaccine that could be ...

The government wants Moderna to push forward with various bird flu vaccines as well as mRNA shots for other influenza strains ...

(Canada), Wantai BioPharm (China), Vaccinogen (US) and Shanghai Zerun Biotechnology Co., Ltd. (China) among others are some of the major players operating in the cancer vaccines market. This ...

A COVID-19 vaccine developed using the technology cleared a phase 1 proof-of-concept study in Australia, but Vicebio is focusing first on RSV, with clinical trials of VXB-211 scheduled to in the ...

Despite continued underperformance in 2024, the biotech sector enters 2025 with a brighter outlook driven by groundbreaking ...

Preventive vaccines such as Gardasil (HPV ... Advanced healthcare infrastructure, high levels of investment in biotechnology, and strong presence of leading pharmaceutical companies driving ...

The plant is expected to have the capacity to produce eight billion doses of vaccines per annum. Shanmugaratnam visited Sapigen Biologix (a subsidiary of Bharat Biotech) at its state-of-the-art ...

These are an adenovirus vector-based vaccine being developed in China by CanSino Biologics and the Beijing Institute of Biotechnology, and Moderna’s mRNA vaccine that is being developed in ...